Update on CAR T-Cell Therapy for Patients with Lymphoma Webinar – September 21, 2022

Webinars

LRF’s free webinars are hour-long interactive programs led by leading lymphoma experts who discuss lymphoma, treatment options, clinical trials, and promising innovative research. Webinars can be listened to live on the telephone or via web streaming. Podcasts of the programs can also be accessed following the live program. Please continue to check this page for updates.

Update on CAR T-Cell Therapy for Patients with Lymphoma Webinar

DATE: Wednesday, September 21, 2022
TIME: 1:00 PM EDT (10:00 AM PDT)

VIRTUAL PROGRAM – This is a virtual event, accessible online and over the phone. Access instructions will be provided after registration. Note: Beacon360 sender of confirmation and reminder emails

Featuring

Caron Jacobson, MD, MMSc
Hematologist/Oncologist
Medical Director, Immune Effector Cell Therapy Program
Assistant Professor of Medicine, Harvard Medical School
Dana-Farber Cancer Institute

Program Overview

  • Understanding CARs – Chimeric Antigen Receptors
  • When to Consider CAR T-Cell Therapy as a Treatment Option for Lymphoma
  • Clinical Trials for CAR T-Cell Therapy
  • Managing Potential Treatment Side Effects
  • The Benefits of CAR T-Cell Therapy
  • Follow-Up Care: What to Expect
  • Question and Answer Session

Ways to Register

VIRTUAL PROGRAM – This is a virtual event, accessible online and over the phone. Access instructions will be emailed after registration. Note: Beacon360 will email confirmation and reminders.

Call: 800-500-9976
Email: mspellman@lymphoma.org

This program is for patients and survivors, caregivers and program supporters. If you are a pharmaceutical industry professional that is interested in attending but your company is not listed as a sponsor, please email vgonzalez@lymphoma.org to learn more about sponsorship.

Disclaimer: The Lymphoma Research Foundation (LRF) is a national nonprofit organization based in the United States with educational programs and resources are intended for a US-based audience. These program and resources address available lymphoma treatments in the United States. and information on drug approvals by the US Food and Drug Administration.

For individuals outside of the US, LRF recommends the Lymphoma Coalition at www.lymphomacoalition.org. The Lymphoma Coalition is a global network of worldwide nonprofit/NGO lymphoma patient organizations with information appropriate for non US-based audiences.

Program Supporters

This program is supported through unrestricted educational grants from: